Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group

March 14, 2024

Noramco Group will be an integrated North American-based API and supply chain services provider.

Chime Biologics to Manufacture Novel Antibody Cancer Immunotherapy for Domain Therapeutics

March 14, 2024

In a new manufacturing pact, Chime Biologics will produce DT-7012, Domain Therapeutics' antibody candidate for treating cancer that will soon be entering Phase I studies.

LGM Pharma Expands Analytical Services

March 13, 2024

The company is investing more than $2 million in its analytical testing services and adding suppository manufacturing capabilities.

Cellares Set to Launch Good Manufacturing Practice–Compliant Cell Shuttle Manufacturing Platform

March 12, 2024

The Cell Shuttle platform will manufacture cell therapies for its first clinical trials by the end of the year.

Jacobs Announces Innovation Hub in Denmark

March 08, 2024

The facility producer’s new innovation hub will offer manufacturing, life sciences, and infrastructure services.

Cellares Innovates With Automated Cell and Gene Therapy Platform

March 07, 2024

Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.

CordenPharma Expands Clinical Peptide Capacity

March 06, 2024

The company is expanding GMP capacities at its Frankfurt site to manufacture early clinical-phase peptide APIs.

Simtra BioPharma Solutions Expands Sterile Fill/Finish Manufacturing Site

February 28, 2024

The company is investing more than $250 million into its Bloomington, Ind. Manufacturing site.

CSL Licenses Cytegrity Lentiviral Vector Production System to Genezen

February 27, 2024

CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen.

Pharmaceutical Outsourcing Present and Future

February 16, 2024

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.